Company information:
Albemarle Life Sciences Llp (No: OC427342)
Address: 10 BOLT COURT, 3RD FLOOR, LONDON, EC4A 3DQ
Status: Active
Incorporated: 15-May-2019
Accounts Next Due: 31-Dec-2024
Next Confirmation Statement Due: 28-May-2024
Industry Class: None Supplied
Current designated LLP Member: MARK EVANS ( DOB: Jan-1964 From: May-2019 )
Current designated LLP Member: MARK EVANS ( DOB: Jan-1964 From: May-2019 )
Current designated LLP Member: MARK EVANS ( DOB: Jan-1964 From: May-2019 )
Current designated LLP Member: MARK EVANS ( DOB: Jan-1964 From: May-2019 )
Current designated LLP Member: MARK EVANS ( DOB: Jan-1964 From: May-2019 )
Current designated LLP Member: MARK EVANS ( DOB: Jan-1964 From: May-2019 )
Current non-designated LLP Member: MAGNUS EDWARD SPENCE-JONES ( DOB: Jul-1989 From: May-2019 )
Current non-designated LLP Member: MAGNUS EDWARD SPENCE-JONES ( DOB: Jul-1989 From: May-2019 )
Current non-designated LLP Member: MAGNUS EDWARD SPENCE-JONES ( DOB: Jul-1989 From: May-2019 )
Current non-designated LLP Member: CATO HENNING STONEX ( DOB: Dec-1963 From: May-2023 )
Resigned designated LLP Member: PARTNERS INVESTMENT COMPANY LLP ( From: May-2019 To: Aug-2021 )
Resigned non-designated LLP Member: CATO HENNING STONEX ( DOB: Dec-1963 From: May-2019 To: May-2019 )
Persons of Significant Control:
Mr Magnus Edward Spence-Jones, 10 Bolt Court, 3rd Floor, London, EC4A 3DQ: Right to appoint and remove members (Notified: 2019-05-15)
Mr Cato Henning Stonex, 10 Bolt Court, 3rd Floor, London, EC4A 3DQ: Ownership of voting rights - More than 25% but not more than 50%, Right to surplus assets - More than 25% but not more than 50% (Notified: 2019-05-15, Ceased: 2019-05-15)
Mr Mark Evans, 10 Bolt Court, 3rd Floor, London, EC4A 3DQ: Ownership of voting rights - 75% or more, Right to surplus assets - 75% or more, Right to appoint and remove members (Notified: 2019-05-15)